New report shows more than 400 medicines and vaccines in development to tackle infectious diseases, including COVID-19
By Andrew Powaleny | July 21, 2020
Throughout history, infectious diseases caused by pathogens such as bacteria or viruses have taken a devastating toll on the lives and security of people around the world. With the ongoing...
Read More
PhRMA’s Lori Reilly joined CSG to discuss the industry’s response to COVID-19 and what it means for states
By Sarah Sutton | July 13, 2020
Recently, Lori Reilly, Chief Operating Officer at PhRMA, participated in a podcast with the Council of State Governments (CSG) to discuss the important work the biopharmaceutical industry is doing...
Read More
Guest Post: From lab to jab: Vaccine development to prevent COVID-19
By Guest Contributor | June 11, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
What scientific experts are saying about vaccine safety
By Andrew Powaleny | June 4, 2020
Vaccines have played a critical role in reducing the spread of, and in some cases, eliminating the threat of many devastating infectious diseases. They are often cited as second only to clean...
Read More
New report shows nearly 260 vaccines in development, including dozens for COVID-19
By Andrew Powaleny | April 23, 2020
Vaccines represent some of the most impactful advances in public health, helping to prevent the spread of many infectious diseases and, in many parts of the world, eliminating some of the most...
Read More
ICYMI: Continued biopharmaceutical action on COVID-19
By Andrew Powaleny | March 6, 2020
Updated 3/11/2020 This week, PhRMA and senior executives and researchers from four member companies met with key policy makers on Capitol Hill to discuss the industry’s response to COVID-19, a...
Read More
Why vaccines work in the fight against measles and other infectious diseases
By Richard Moscicki, M.D. | February 13, 2019
It is often said that vaccines are only second to clean drinking water in terms of public health impact. In recent years, misinformation about vaccines, especially childhood vaccinations, has...
Read More
Medicare Monday: Helping beneficiaries access vaccines
By Nicole Longo | December 18, 2017
Last month, we released a State of Vaccines report, as well as an update to our Medicines in Development for Vaccines report, which shared exciting information about the 264 vaccines currently in...
Read More
New report and event examine the new era of vaccines
By Andrew Powaleny | November 9, 2017
Today, leading minds will come together for an in-depth conversation centered on vaccines – their critical role in warding off disease, the innovative science powering breakthroughs in their...
Read More
Medicare Monday: Strengthening access to vaccines for seniors
By Nicole Longo | August 14, 2017
This month, we’re celebrating National Immunization Awareness Month! Although children may come to mind first when we think of vaccination, access to immunization is just as important for older...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
